Open AccessThe Use of Venetoclax + Azacitidine for Acute Myeloid Leukemia & IDH1/2 Mutations
Author(s) -
Dibash Kumar Das
Publication year - 2022
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000831932.35619.26
Subject(s) - myeloid leukemia , idh2 , medicine , idh1 , venetoclax , oncology , induction chemotherapy , azacitidine , isocitrate dehydrogenase , leukemia , chemotherapy , myeloid , cancer , cancer research , mutation , dna methylation , biology , genetics , gene , biochemistry , enzyme , gene expression , chronic lymphocytic leukemia
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom